Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Scientists create functioning beta cells that could treat diabetes

18 April 2016

By Paul Waldron

Appeared in BioNews 847

Two new studies report the creation of functioning human beta cells, which can release insulin in response to changes in blood sugar, holding promise for the treatment of diabetes.

In the first study, published in Nature Communications, scientists extracted fat cells from a 50-year-old subject and turned these into stem cells. They then used a 'synthetic gene network' to programme the cells to become functioning beta cells that secrete insulin.

Professor Martin Fussenegger of ETH Zurich and his team first identified the specific growth factors that are involved in the normal development of stem cells into beta cells. The timing of the release of these growth factors is crucial to the process but had been hard to recreate.

Scientists had tried adding growth factors directly to cells growing in the laboratory, but this had proved tricky. 'It's not only really hard to add just the right quantities of these components at just the right time, it's also inefficient and impossible to scale up,' said Professor Fussenegger.

His team created a synthetic gene network, which they added to the stem cells, instructing the cell to produce the growth factors at exactly the right time and in precisely the right amounts. The beta cells produced in this way closely resembled normal beta cells and also contained insulin.

They hope to develop the process into an individualised treatment for diabetes using a patient's own fat cells.

In a second study, carried out at the Salk Institute in La Jolla, California, and published in Cell Metabolism, researchers solved a common problem encountered in this area. Previously, new beta cells generated in the laboratory would be 'stuck' at a certain stage of development and be unable to respond to glucose, even though they could produce insulin.

The researchers noted that healthy beta cells produce a protein called ERR-gamma in high levels. Genetically modified mice that did not produce ERR-gamma were also unable to produce insulin in response to a spike in blood glucose.

So the team, led by Professor Ronald Evans, programmed laboratory grown human beta cells, derived from induced pluripotent stem cells, to produce extra ERR-gamma. 'Those cells in culture began to respond to glucose and release insulin,' said Professor Evans.

When these beta cells were injected into mice with diabetes, they also restored normal blood glucose control.

'I believe this work transitions us to a new era in creating functional beta cells at will,' said Professor Evans. His team also hopes develop these techniques for use in human trials in the next few years.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

07 August 2017 - by Annabel Slater 
A proof-of-concept study in mice has demonstrated how skin grafts could deliver gene therapy for obesity and diabetes...
30 January 2017 - by Arit Udoh 
Insulin-producing cells from pancreases grown in rats can cure diabetes when transplanted into mice, according to a study...
17 October 2016 - by Dr Rosie Gilchrist 
Vitamins A and C help to convert adult cells into stem cells by performing a cell 'reset', erasing their epigenetic memory, a study has found...
01 August 2016 - by Annabel Slater 
A new stem cell treatment has reversed scarring in heart failure patients by 40 percent, and also improved recovery and survival, a small-scale trial has demonstrated...

13 October 2014 - by Julianna Photopoulos 
Millions of insulin-producing beta cells have been manufactured in the laboratory using human stem cells by scientists at Harvard University...
06 May 2014 - by Dr Gabrielle Samuel 
Researchers have transformed embryonic stem cells from a diabetic woman into insulin-producing beta cells, a study in Nature reports...
10 February 2014 - by Chris Hardy 
Stem cells have reversed the equivalent of type 1 diabetes in genetically modified mice. Using skin cells as a starting point, researchers formed pancreas precursor cells that produced insulin when injected into mice...
13 January 2014 - by Dr Shanya Sivakumaran 
Scientists have identified mutations in two genes that cause neonatal diabetes, a rare condition affecting around 1 in 100,000 births...
11 March 2013 - by Reuben Harwood 
Genetic analysis of a family predisposed to type 1 diabetes (T1D) has uncovered the first kind of T1D to be caused by a single gene mutation...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation